trial

Striatal Connectivity and Clinical Outcome in Psychosis

NCTId NCT02822092
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 196 (actual)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2023-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
196 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2016-07
Primary completion
2023-12
Eligibility
ALL · 15 Years · 40 Years

Interventions & indications

Drugs
Aripiprazole

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor
National Institutes of Health (NIH)Collaborator

Investigators

1
Anil Malhotra, MDPrincipal Investigator

Sites

1 total
Glen Oaks, United States

Facts & assertions

4 sourced
Enrollment
196
Phase
NA
Primary Completion Date
2023-12
Status
COMPLETED
relationships
The graph out of here
drug
Aripiprazole
drug
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
collaborator
National Institutes of Health (NIH)
company
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
investigator
Anil Malhotra, MD
person